EUROPE MARINE BIOTECHNOLOGY MARKET FORECAST 2018-2026

EUROPE MARINE BIOTECHNOLOGY MARKET FORECAST 2018-2026

  • February 2018 •
  • 89 pages •
  • Report ID: 5039874
KEY FINDINGS
The Europe marine biotechnology market generated a revenue of $1258 million in the year 2017. Over the forecast period of 2018-2026, the market is predicted to showcase a CAGR of 5.47% and raise a net total of $2009 million.

MARKET INSIGHTS
Pharmaceutical and biotechnology market, nutrients and dietary supplements market and increasing healthcare infrastructure in Europe are contributing (either directly or indirectly) to the growth of the marine biotechnology market in Europe. The market also finds application in cosmetics and personal care sectors. U.K, Germany and the Nordics are some of the significant players in this market. However, the high cost of R&D investment and lack of skilled man force, coupled with the involved complex technologies are interfering with the growth of the marine biotechnology market.

COMPETITIVE INSIGHTS
Companies like New England Biolabs Inc, Geomarine Biotech, Abbott, Seppic Sa, Biotech Marine (Subsidiary Of Air Liquid Group), Aker Biomarine, Biolume Inc, Qingdao Codo International Ltd, Nutrex Hawaii Incorporated, Sea Run Holding, BASF Se, FMC Health And Nutrition, Prolume Ltd and Cyanotech Corporation are increasingly engaged in this market.
Country=Europe Industry=Biotechnology ParentIndustry=LifeSciences Date=201802 Topic=MarketSize Publisher=InkwoodResearch Price=2000